www.scri.ngen.com/hydrazine_sulfate.html
Syracuse Cancer Research Institute offers extensive information on hydrazine sulfate. This website includes research information and results of double blind studies carried out by Dr. Michael Gershanovich, director of oncology at the Petrov Research Institute of Oncology in Leningrad and at Harbor-UCLA Medical Center. It also offers information on the benefits of hydrazine sulfate for cancer patients using alternative therapies, allopathic therapies, or a combination of both.